Helmerich & Payne officer plans $450K share sale
Helmerich & Payne, Inc. (HP) is the issuer for which officer Michael Lennox has filed a Form 144 notice to sell restricted securities.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Helmerich & Payne, Inc. (HP) is the issuer for which officer Michael Lennox has filed a Form 144 notice to sell restricted securities. The notice covers a proposed sale of 10,000 shares of common stock of HP through Fidelity Brokerage Services LLC, with an aggregate sale price of $450,000.00, to be sold on the NYSE on or after September 1, 2026.
The securities to be sold were acquired through multiple restricted stock vesting compensation grants from 2019 through 2025. The filing also reports that Lennox sold 5,000 shares for $175,000.00 on July 22, 2026 and another 5,000 shares for $200,000.00 on August 10, 2026 during the prior three months.
Key Figures
Key Terms
Form 144 regulatory
Rule 144 regulatory
restricted stock vesting financial
attorney-in-fact regulatory
aggregate sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Helmerich & Payne, Inc. (HP)?
AI-generated analysis. How Rhea-AI works. Not financial advice.